Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B

Background/Aims: The long‐term outcomes in hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B are distinct from those in HBeAg‐positive chronic hepatitis. However, the molecular virological factors that contribute to the progression of liver disease in this special clinical setting remain la...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Liver international 2005-06, Vol.25 (3), p.564-570
Hauptverfasser: Lin, Chih-Lin, Liao, Li-Ying, Wang, Chaur-Shine, Chen, Pei-Jer, Lai, Ming-Yang, Chen, Ding-Shinn, Kao, Jia-Horng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 570
container_issue 3
container_start_page 564
container_title Liver international
container_volume 25
creator Lin, Chih-Lin
Liao, Li-Ying
Wang, Chaur-Shine
Chen, Pei-Jer
Lai, Ming-Yang
Chen, Ding-Shinn
Kao, Jia-Horng
description Background/Aims: The long‐term outcomes in hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B are distinct from those in HBeAg‐positive chronic hepatitis. However, the molecular virological factors that contribute to the progression of liver disease in this special clinical setting remain largely unknown. We thus investigated the association of hepatitis B virus (HBV) genotypes as well as precore/basal core‐promoter mutations with the clinical and virological characteristics of patients with HBeAg‐negative chronic hepatitis B in Taiwan. Methods: HBV genotypes and sequences of precore and basal core‐promoter regions of the HBV genome were determined in 174 HBeAg‐negative chronic HBV infection patients including 62 inactive carriers and 112 with different stages of liver disease. Results: HBV carriers with older age (>50 years) (odds ratio, 9.09; 95% confidence interval (CI), 3.22–25, P
doi_str_mv 10.1111/j.1478-3231.2005.01041.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67865810</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67865810</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4851-1a48cb256b9d9bb3cb0f91abce6fd044029a36306bdff5eb8791bccf7ff35c003</originalsourceid><addsrcrecordid>eNqNkc1u3CAQgFGUqEnTvkLEqTe7YIxtDj10V_mTVsmlbXpDgIcNW_9swN5sXiDPXdxdbdpbuTCC75uBGYQwJSmN6_MqpXlZJSxjNM0I4SmhJKfp9gidHS6OD3HGTtH7EFaEUCE4fYdOKRdREPkZep2poBpseg_J2vdtP4DH7TiobsC9xY-wVoMbXMAzvHF-DFh1NY7g0kMIru8mqHGbKNUugAqAXfePBdEY3BK6pINlPN0ANo--75z5G_uATqxqAnzc7-fo-9Xlt_lNsri_vp1_XSQmrzhNqMorozNeaFELrZnRxAqqtIHC1iTPSSYUKxgpdG0tB12VgmpjbGkt44YQdo4-7fLGLzyNEAbZumCgaVQH_RhkUVYFr-gEVjvQ-D4ED1auvWuVf5GUyGkGciWn9sqp1XKagfwzA7mN6sW-xqhbqN_EfdMj8GUHPLsGXv47sVzc_pii6Cc734UBtgdf-V_x_azk8uHuWt4Q-nM-e1jInP0GXXOnDg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67865810</pqid></control><display><type>article</type><title>Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Lin, Chih-Lin ; Liao, Li-Ying ; Wang, Chaur-Shine ; Chen, Pei-Jer ; Lai, Ming-Yang ; Chen, Ding-Shinn ; Kao, Jia-Horng</creator><creatorcontrib>Lin, Chih-Lin ; Liao, Li-Ying ; Wang, Chaur-Shine ; Chen, Pei-Jer ; Lai, Ming-Yang ; Chen, Ding-Shinn ; Kao, Jia-Horng</creatorcontrib><description>Background/Aims: The long‐term outcomes in hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B are distinct from those in HBeAg‐positive chronic hepatitis. However, the molecular virological factors that contribute to the progression of liver disease in this special clinical setting remain largely unknown. We thus investigated the association of hepatitis B virus (HBV) genotypes as well as precore/basal core‐promoter mutations with the clinical and virological characteristics of patients with HBeAg‐negative chronic hepatitis B in Taiwan. Methods: HBV genotypes and sequences of precore and basal core‐promoter regions of the HBV genome were determined in 174 HBeAg‐negative chronic HBV infection patients including 62 inactive carriers and 112 with different stages of liver disease. Results: HBV carriers with older age (&gt;50 years) (odds ratio, 9.09; 95% confidence interval (CI), 3.22–25, P&lt;0.001) and basal core‐promoter mutant of HBV (odds ratio, 4.12; 95% CI, 1.41–12.03, P=0.01) were associated with the development of liver cirrhosis and hepatocellular carcinoma (HCC). The gender‐related risk factors associated with the development of liver cirrhosis and HCC were further analyzed, and basal core‐promoter mutant was only associated with the development of liver cirrhosis and HCC in male carriers (odds ratio, 4.35; 95% CI, 1.30–14.52, P=0.02). Conclusions: The risk of development of liver cirrhosis and HCC is significantly increased in patients with advanced age as well as with basal core‐promoter mutant of HBV. In addition, basal core‐promoter mutant might contribute to the gender difference of the progression of liver disease in HBeAg‐negative chronic hepatitis B in Taiwan.</description><identifier>ISSN: 1478-3223</identifier><identifier>EISSN: 1478-3231</identifier><identifier>DOI: 10.1111/j.1478-3231.2005.01041.x</identifier><identifier>PMID: 15910494</identifier><language>eng</language><publisher>Oxford, UK: Munksgaard International Publishers</publisher><subject>Adult ; Age Distribution ; Aged ; basal core promoter ; Carrier State - virology ; chronic hepatitis B ; Disease Progression ; Female ; Genotype ; Hepatitis B e Antigens - genetics ; hepatitis B genotype ; Hepatitis B virus - genetics ; hepatitis B virus mutant ; Hepatitis B, Chronic - epidemiology ; Hepatitis B, Chronic - physiopathology ; Hepatitis B, Chronic - virology ; hepatitis e antigen ; hepatocellular carcinoma ; Humans ; liver cirrhosis ; Liver Cirrhosis - epidemiology ; Liver Cirrhosis - physiopathology ; Liver Cirrhosis - virology ; Male ; Middle Aged ; Promoter Regions, Genetic - genetics ; Risk Factors ; Sex Distribution ; Taiwan - epidemiology</subject><ispartof>Liver international, 2005-06, Vol.25 (3), p.564-570</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4851-1a48cb256b9d9bb3cb0f91abce6fd044029a36306bdff5eb8791bccf7ff35c003</citedby><cites>FETCH-LOGICAL-c4851-1a48cb256b9d9bb3cb0f91abce6fd044029a36306bdff5eb8791bccf7ff35c003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1478-3231.2005.01041.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1478-3231.2005.01041.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15910494$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lin, Chih-Lin</creatorcontrib><creatorcontrib>Liao, Li-Ying</creatorcontrib><creatorcontrib>Wang, Chaur-Shine</creatorcontrib><creatorcontrib>Chen, Pei-Jer</creatorcontrib><creatorcontrib>Lai, Ming-Yang</creatorcontrib><creatorcontrib>Chen, Ding-Shinn</creatorcontrib><creatorcontrib>Kao, Jia-Horng</creatorcontrib><title>Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B</title><title>Liver international</title><addtitle>Liver Int</addtitle><description>Background/Aims: The long‐term outcomes in hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B are distinct from those in HBeAg‐positive chronic hepatitis. However, the molecular virological factors that contribute to the progression of liver disease in this special clinical setting remain largely unknown. We thus investigated the association of hepatitis B virus (HBV) genotypes as well as precore/basal core‐promoter mutations with the clinical and virological characteristics of patients with HBeAg‐negative chronic hepatitis B in Taiwan. Methods: HBV genotypes and sequences of precore and basal core‐promoter regions of the HBV genome were determined in 174 HBeAg‐negative chronic HBV infection patients including 62 inactive carriers and 112 with different stages of liver disease. Results: HBV carriers with older age (&gt;50 years) (odds ratio, 9.09; 95% confidence interval (CI), 3.22–25, P&lt;0.001) and basal core‐promoter mutant of HBV (odds ratio, 4.12; 95% CI, 1.41–12.03, P=0.01) were associated with the development of liver cirrhosis and hepatocellular carcinoma (HCC). The gender‐related risk factors associated with the development of liver cirrhosis and HCC were further analyzed, and basal core‐promoter mutant was only associated with the development of liver cirrhosis and HCC in male carriers (odds ratio, 4.35; 95% CI, 1.30–14.52, P=0.02). Conclusions: The risk of development of liver cirrhosis and HCC is significantly increased in patients with advanced age as well as with basal core‐promoter mutant of HBV. In addition, basal core‐promoter mutant might contribute to the gender difference of the progression of liver disease in HBeAg‐negative chronic hepatitis B in Taiwan.</description><subject>Adult</subject><subject>Age Distribution</subject><subject>Aged</subject><subject>basal core promoter</subject><subject>Carrier State - virology</subject><subject>chronic hepatitis B</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Genotype</subject><subject>Hepatitis B e Antigens - genetics</subject><subject>hepatitis B genotype</subject><subject>Hepatitis B virus - genetics</subject><subject>hepatitis B virus mutant</subject><subject>Hepatitis B, Chronic - epidemiology</subject><subject>Hepatitis B, Chronic - physiopathology</subject><subject>Hepatitis B, Chronic - virology</subject><subject>hepatitis e antigen</subject><subject>hepatocellular carcinoma</subject><subject>Humans</subject><subject>liver cirrhosis</subject><subject>Liver Cirrhosis - epidemiology</subject><subject>Liver Cirrhosis - physiopathology</subject><subject>Liver Cirrhosis - virology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Promoter Regions, Genetic - genetics</subject><subject>Risk Factors</subject><subject>Sex Distribution</subject><subject>Taiwan - epidemiology</subject><issn>1478-3223</issn><issn>1478-3231</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u3CAQgFGUqEnTvkLEqTe7YIxtDj10V_mTVsmlbXpDgIcNW_9swN5sXiDPXdxdbdpbuTCC75uBGYQwJSmN6_MqpXlZJSxjNM0I4SmhJKfp9gidHS6OD3HGTtH7EFaEUCE4fYdOKRdREPkZep2poBpseg_J2vdtP4DH7TiobsC9xY-wVoMbXMAzvHF-DFh1NY7g0kMIru8mqHGbKNUugAqAXfePBdEY3BK6pINlPN0ANo--75z5G_uATqxqAnzc7-fo-9Xlt_lNsri_vp1_XSQmrzhNqMorozNeaFELrZnRxAqqtIHC1iTPSSYUKxgpdG0tB12VgmpjbGkt44YQdo4-7fLGLzyNEAbZumCgaVQH_RhkUVYFr-gEVjvQ-D4ED1auvWuVf5GUyGkGciWn9sqp1XKagfwzA7mN6sW-xqhbqN_EfdMj8GUHPLsGXv47sVzc_pii6Cc734UBtgdf-V_x_azk8uHuWt4Q-nM-e1jInP0GXXOnDg</recordid><startdate>200506</startdate><enddate>200506</enddate><creator>Lin, Chih-Lin</creator><creator>Liao, Li-Ying</creator><creator>Wang, Chaur-Shine</creator><creator>Chen, Pei-Jer</creator><creator>Lai, Ming-Yang</creator><creator>Chen, Ding-Shinn</creator><creator>Kao, Jia-Horng</creator><general>Munksgaard International Publishers</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200506</creationdate><title>Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B</title><author>Lin, Chih-Lin ; Liao, Li-Ying ; Wang, Chaur-Shine ; Chen, Pei-Jer ; Lai, Ming-Yang ; Chen, Ding-Shinn ; Kao, Jia-Horng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4851-1a48cb256b9d9bb3cb0f91abce6fd044029a36306bdff5eb8791bccf7ff35c003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Age Distribution</topic><topic>Aged</topic><topic>basal core promoter</topic><topic>Carrier State - virology</topic><topic>chronic hepatitis B</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Genotype</topic><topic>Hepatitis B e Antigens - genetics</topic><topic>hepatitis B genotype</topic><topic>Hepatitis B virus - genetics</topic><topic>hepatitis B virus mutant</topic><topic>Hepatitis B, Chronic - epidemiology</topic><topic>Hepatitis B, Chronic - physiopathology</topic><topic>Hepatitis B, Chronic - virology</topic><topic>hepatitis e antigen</topic><topic>hepatocellular carcinoma</topic><topic>Humans</topic><topic>liver cirrhosis</topic><topic>Liver Cirrhosis - epidemiology</topic><topic>Liver Cirrhosis - physiopathology</topic><topic>Liver Cirrhosis - virology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Promoter Regions, Genetic - genetics</topic><topic>Risk Factors</topic><topic>Sex Distribution</topic><topic>Taiwan - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, Chih-Lin</creatorcontrib><creatorcontrib>Liao, Li-Ying</creatorcontrib><creatorcontrib>Wang, Chaur-Shine</creatorcontrib><creatorcontrib>Chen, Pei-Jer</creatorcontrib><creatorcontrib>Lai, Ming-Yang</creatorcontrib><creatorcontrib>Chen, Ding-Shinn</creatorcontrib><creatorcontrib>Kao, Jia-Horng</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Liver international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Chih-Lin</au><au>Liao, Li-Ying</au><au>Wang, Chaur-Shine</au><au>Chen, Pei-Jer</au><au>Lai, Ming-Yang</au><au>Chen, Ding-Shinn</au><au>Kao, Jia-Horng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B</atitle><jtitle>Liver international</jtitle><addtitle>Liver Int</addtitle><date>2005-06</date><risdate>2005</risdate><volume>25</volume><issue>3</issue><spage>564</spage><epage>570</epage><pages>564-570</pages><issn>1478-3223</issn><eissn>1478-3231</eissn><abstract>Background/Aims: The long‐term outcomes in hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B are distinct from those in HBeAg‐positive chronic hepatitis. However, the molecular virological factors that contribute to the progression of liver disease in this special clinical setting remain largely unknown. We thus investigated the association of hepatitis B virus (HBV) genotypes as well as precore/basal core‐promoter mutations with the clinical and virological characteristics of patients with HBeAg‐negative chronic hepatitis B in Taiwan. Methods: HBV genotypes and sequences of precore and basal core‐promoter regions of the HBV genome were determined in 174 HBeAg‐negative chronic HBV infection patients including 62 inactive carriers and 112 with different stages of liver disease. Results: HBV carriers with older age (&gt;50 years) (odds ratio, 9.09; 95% confidence interval (CI), 3.22–25, P&lt;0.001) and basal core‐promoter mutant of HBV (odds ratio, 4.12; 95% CI, 1.41–12.03, P=0.01) were associated with the development of liver cirrhosis and hepatocellular carcinoma (HCC). The gender‐related risk factors associated with the development of liver cirrhosis and HCC were further analyzed, and basal core‐promoter mutant was only associated with the development of liver cirrhosis and HCC in male carriers (odds ratio, 4.35; 95% CI, 1.30–14.52, P=0.02). Conclusions: The risk of development of liver cirrhosis and HCC is significantly increased in patients with advanced age as well as with basal core‐promoter mutant of HBV. In addition, basal core‐promoter mutant might contribute to the gender difference of the progression of liver disease in HBeAg‐negative chronic hepatitis B in Taiwan.</abstract><cop>Oxford, UK</cop><pub>Munksgaard International Publishers</pub><pmid>15910494</pmid><doi>10.1111/j.1478-3231.2005.01041.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1478-3223
ispartof Liver international, 2005-06, Vol.25 (3), p.564-570
issn 1478-3223
1478-3231
language eng
recordid cdi_proquest_miscellaneous_67865810
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Age Distribution
Aged
basal core promoter
Carrier State - virology
chronic hepatitis B
Disease Progression
Female
Genotype
Hepatitis B e Antigens - genetics
hepatitis B genotype
Hepatitis B virus - genetics
hepatitis B virus mutant
Hepatitis B, Chronic - epidemiology
Hepatitis B, Chronic - physiopathology
Hepatitis B, Chronic - virology
hepatitis e antigen
hepatocellular carcinoma
Humans
liver cirrhosis
Liver Cirrhosis - epidemiology
Liver Cirrhosis - physiopathology
Liver Cirrhosis - virology
Male
Middle Aged
Promoter Regions, Genetic - genetics
Risk Factors
Sex Distribution
Taiwan - epidemiology
title Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T07%3A27%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Basal%20core-promoter%20mutant%20of%20hepatitis%20B%20virus%20and%20progression%20of%20liver%20disease%20in%20hepatitis%20B%20e%20antigen-negative%20chronic%20hepatitis%20B&rft.jtitle=Liver%20international&rft.au=Lin,%20Chih-Lin&rft.date=2005-06&rft.volume=25&rft.issue=3&rft.spage=564&rft.epage=570&rft.pages=564-570&rft.issn=1478-3223&rft.eissn=1478-3231&rft_id=info:doi/10.1111/j.1478-3231.2005.01041.x&rft_dat=%3Cproquest_cross%3E67865810%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67865810&rft_id=info:pmid/15910494&rfr_iscdi=true